STERIS exec reports 208-share tax withholding

STERIS plc senior executive Julia Madsen reported a routine tax-withholding share disposition tied to vesting equity compensation.

Rhea-AI Filing Summary

STERIS plc senior executive Julia Madsen reported a routine tax-withholding share disposition tied to vesting equity compensation. On June 1, 2026, 578 restricted shares vested, and 208 of those shares were withheld to cover required taxes based on the NYSE closing market price that day.

After this transaction, she directly holds 10,502 ordinary shares, including 3,425 restricted shares. The restrictions on these ordinary shares are scheduled to lapse in tranches between June 2026 and June 2028.

Insider Trade Summary

Exercise Price or Tax Liability: 208 shares

Exercise Price or Tax Liability 1 txn

Insider Madsen Julia

Role Sr. VP and GM, Life Sciences

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Ordinary Shares	208	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 10,502 shares (Direct)

Footnotes (2)

1. F1. 208 shares were withheld from the 578 restricted shares that vested on June 1, 2026. These 208 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026.
2. F2. As of June 1, 2026, 3,425 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028.

Key Figures

Tax-withheld shares: 208 shares Restricted shares vested: 578 shares Post-transaction holdings: 10,502 shares +4 more

7 metrics

Tax-withheld shares 208 shares Shares withheld to cover taxes from vested restricted shares on June 1, 2026

Restricted shares vested 578 shares Restricted shares that vested on June 1, 2026

Post-transaction holdings 10,502 shares Ordinary shares directly held after June 1, 2026 transaction

Restricted shares outstanding 3,425 shares Restricted ordinary shares as of June 1, 2026

2026 vesting tranches 352, 666, 542 shares Restricted shares with restrictions lapsing June 2, 3, and 4, 2026

2027 vesting tranches 666, 542 shares Restricted shares with restrictions lapsing June 3 and 4, 2027

2028 vesting tranche 666 shares Restricted shares with restrictions lapsing June 5, 2028

Key Terms

restricted shares, tax-withholding disposition, NYSE closing market price

3 terms

restricted shares financial

"578 restricted shares vested on June 1, 2026, and 3,425 remain restricted."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

tax-withholding disposition financial

"The 208 shares are classified as a tax-withholding disposition to satisfy required taxes."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

NYSE closing market price financial

"These vested shares were valued at the NYSE closing market price on June 1, 2026."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did STERIS (STE) executive Julia Madsen report in this Form 4?

Julia Madsen reported a tax-withholding disposition of 208 STERIS ordinary shares. These shares were withheld from 578 restricted shares that vested on June 1, 2026, to satisfy employment-related tax obligations as determined by the company.

How many STERIS (STE) shares were withheld for Julia Madsen’s taxes?

A total of 208 ordinary shares were withheld to cover taxes. These shares came from 578 restricted shares that vested on June 1, 2026, and were valued at the NYSE closing market price for that date.

How many STERIS (STE) shares does Julia Madsen hold after the transaction?

Following the tax-withholding disposition, Julia Madsen holds 10,502 ordinary STERIS shares directly. This total includes both unrestricted and 3,425 restricted shares that will vest over multiple dates between June 2026 and June 2028.

Is Julia Madsen’s STERIS (STE) share disposition an open-market sale?

The disposition is not an open-market sale; it is a tax-withholding event. The 208 shares were withheld by STERIS from vested restricted shares to satisfy required tax obligations under applicable employment or tax laws.

What is the vesting schedule for Julia Madsen’s remaining restricted STERIS (STE) shares?

As of June 1, 2026, 3,425 ordinary shares remain restricted. Restrictions lapse in tranches: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027; and 666 on June 5, 2028.

What role does Julia Madsen hold at STERIS (STE)?

Julia Madsen serves as Senior Vice President and General Manager, Life Sciences at STERIS. Her Form 4 filing reflects equity compensation activity and related tax withholding, rather than discretionary buying or selling in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Madsen Julia

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP and GM, Life Sciences

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/01/2026		F		208(1)	D	$0	10,502(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 208 shares were withheld from the 578 restricted shares that vested on June 1, 2026. These 208 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026.

2. As of June 1, 2026, 3,425 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)